TABLE 2.
Factor | Univariate analysis |
Multivariate analysisa |
||||
---|---|---|---|---|---|---|
OR | 95% CI | P valueb | OR | 95% CI | P value | |
Age (per year) | 0.98 | 0.95–1.02 | 0.335 | |||
Female sex | 0.35 | 0.12–1.02 | 0.055 | 0.28 | 0.08–1.01 | 0.052 |
Allogeneic stem cell transplantation | 1.47 | 0.47–4.64 | 0.508 | |||
GVHDc | 3.92 | 1.30–11.84 | 0.016 | 7.00 | 1.67–29.42 | 0.008 |
Concomitant PPI | 0.76 | 0.25–2.31 | 0.634 | |||
Diarrhea | 1.51 | 0.44–5.24 | 0.514 | |||
Posaconazole DRT | 0.15 | 0.04–0.58 | 0.005 | 0.07 | 0.01–0.39 | 0.002 |
Hosmer-Lemeshow goodness-of-fit chi-square value, 5.284 (P = 0.382); ROC area under the curve of the model, 0.84 (95% CI, 0.74 to 0.94).
P values of <0.2, the cutoff for inclusion of the respective variables in the multivariable model, are in bold.
Sixty percent of patients receiving DRT and 40% of patients receiving OS had GVHD grade 3 or 4; the rest had GVHD grade 1 or 2.